Cross Country Healthcare (CCRN) Common Equity: 2009-2025
Historic Common Equity for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $408.1 million.
- Cross Country Healthcare's Common Equity fell 389.67% to $408.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.1 million, marking a year-over-year decrease of 389.67%. This contributed to the annual value of $419.0 million for FY2024, which is 1041.2% down from last year.
- Per Cross Country Healthcare's latest filing, its Common Equity stood at $408.1 million for Q3 2025, which was down 389.67% from $412.2 million recorded in Q2 2025.
- Over the past 5 years, Cross Country Healthcare's Common Equity peaked at $470.3 million during Q2 2023, and registered a low of $173.7 million during Q1 2021.
- Its 5-year average for Common Equity is $387.9 million, with a median of $419.0 million in 2024.
- Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 11381.82% in 2022, then crashed by 1067.52% in 2025.
- Over the past 5 years, Cross Country Healthcare's Common Equity (Quarter) stood at $297.5 million in 2021, then soared by 51.74% to $451.5 million in 2022, then rose by 3.58% to $467.7 million in 2023, then decreased by 10.41% to $419.0 million in 2024, then decreased by 2.58% to $408.1 million in 2025.
- Its last three reported values are $408.1 million in Q3 2025, $412.2 million for Q2 2025, and $418.2 million during Q1 2025.